AI proves 93% accurate in identifying colorectal cancer

Researchers developed artificial intelligence (AI) software to identify colorectal tumor in histology images.

“Many recent studies have suggested using machine learning techniques to classify, localize, and segment tumor areas in histology images,” wrote author Hongjun Yoon of the National Cancer Center in Goyang, South Korea, and colleagues, in the Journal of Digital Imaging. “Deep neural networks (DNNs) are used extensively to extract and learn features of subjects; DNNs specifically adapted to image data, called convolutional neural networks (CNNs), can effectively classify or locate tumors; however, comparatively few studies have examined CRC using these techniques.”

The AI improved over the 10-day window of the study—reaching a peak sensitivity of 93 percent and a specificity of 92 percent.

Read more at Radiology Business by clicking the link below:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.